缺乏和阿尔茨海默病的发生
Liviu Aron1, Zhen Kai Ngian1, Chenxi Qiu1
1Department of Genetics, Harvard Medical School, Boston, MA, USA.
Nature
|August 6, 2025
概括
内生 (Li) 水平在老化的大脑中降低,在轻度认知障碍和阿尔茨海默症中降低
科学领域:
- 神经科学
- 分子生物学
- 老年学
背景情况:
- 阿尔茨海默病 (AD) 的早期分子变化尚不清楚.
- 大脑内源性 (Li) 调节及其在认知衰老中的作用尚不清楚.
研究的目的:
- 研究内源性在衰老过程中的认知保护作用.
- 确定轻度认知障碍 (MCI) 和AD的水平是否发生变化.
- 探索阿尔茨海默病的替代疗法.
主要方法:
- 在人脑样本中分析金属含量 (MCI和AD).
- 在野生类型和AD小鼠模型中,的耗.
- 评估粉样β沉积,酸积累,神经炎症,突触损失和认知功能.
- 单核RNA测序 (snRNA-seq) 用于分析转录组变化.
- 在小鼠模型中使用酸盐治疗.
主要成果:
- 在MCI和AD大脑中,是唯一被分析的金属显著减少.
- 氨基酸封存进一步降低了AD中的的生物可用性.
- 在小鼠中,耗增加了粉样β和酸病理,引起神经炎症,导致神经元损伤,加速认知衰退.
- 缺乏改变了脑细胞的转录体,与AD相关的变化重叠.
- 在阿尔茨海默病和老年小鼠中,酸盐治疗预防了病态变化和记忆丧失.
结论:
- 内源在认知维护和大脑健康方面起着至关重要的作用.
- 平衡中断是阿尔茨海默病发病的一个早期事件.
- 替代疗法,特别是用粉样脱离盐,显示出预防和治疗阿尔茨海默病的潜力.
相关概念视频
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K
Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
Mania and Antimanic Drugs: Overview
321
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
321
Role of Neurotransmitters in Memory
986
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
986
Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165


